Literature DB >> 21407755

The Use of ACTH and Cortisone in the Treatment of Hematological Disorders.

C C Sturgis, F H Bethell, M C Meyers.   

Abstract

Entities:  

Year:  1952        PMID: 21407755      PMCID: PMC2248859     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  9 in total

1.  Acquired hemolytic anemia treated with corticotropin.

Authors:  W R BEST; L R LIMARZI; H G PONCHER
Journal:  J Am Med Assoc       Date:  1951-10-27

2.  The "humors" and idiopathic thrombocytopenic purpura.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-10       Impact factor: 22.113

3.  The effect of adrenocorticotrophic hormone (ACTH) in idiopathic acquired hemolytic anemia as related to the hemolytic mechanisms.

Authors:  F H GARDNER; A E McELFRESH; J W HARRIS; L K DIAMOND
Journal:  J Lab Clin Med       Date:  1951-03

4.  Clinical trials of ACTH in haemolytic anaemia.

Authors:  L S P DAVIDSON; J J R DUTHIE; R H GIRDWOOD; R J G SINCLAIR
Journal:  Br Med J       Date:  1951-03-31

5.  The treatment of acquired hemolytic anemia with adrenocorticotrophic hormone (ACTH).

Authors:  W DAMESHEK; M C ROSENTHAL; L I SCHWARTZ
Journal:  N Engl J Med       Date:  1950-01-25       Impact factor: 91.245

6.  Effect of corticotrophin and cortisone on the blood in various disorders in man.

Authors:  M M WINTROBE; G E CARTWRIGHT; J G PALMER; W J KUHNS; L T SAMUELS
Journal:  AMA Arch Intern Med       Date:  1951-09

7.  The role of adrenal steroids in infection and immunity.

Authors:  E H KASS; M FINLAND
Journal:  N Engl J Med       Date:  1951-03-29       Impact factor: 91.245

8.  Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology.

Authors:  R S EVANS; K TAKAHASHI; R T DUANE; R PAYNE; C LIU
Journal:  AMA Arch Intern Med       Date:  1951-01

9.  Adrenocorticotropic hormone- and cortisone-induced regression of lymphoid tumors in man; a preliminary report.

Authors:  O H PEARSON; L P ELIEL
Journal:  Cancer       Date:  1949-11       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.